Acute and continuation risperidone monotherapy in mania

Human Psychopharmacology

Volumn 19, Issue 1, 2004, Pages 41-45

  Vieta, Eduard ^a   Brugué, Esteve ^a   Goikolea, José Manuel ^a   Sánchez Moreno, Jose ^a   Reinares, María ^a   Comes, Mercè ^a   Colom, Francesc ^a   Martínez Arán, Anabel ^a   Benabarre, Antoni ^a   Torrent, Carla ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bipolar disorder; Mania; Monotherapy; Risperidone

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; RISPERIDONE; THYROID HORMONE;

ACUTE DISEASE; ADULT; AKATHISIA; ANALYTIC METHOD; ARTICLE; BIPOLAR MANIA; BODY WEIGHT DISORDER; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GALACTORRHEA; HAMILTON SCALE; HUMAN; HYPOKINESIA; HYPOTENSION; IMPOTENCE; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOOD DISORDER; MULTICENTER STUDY; NEGATIVE SYNDROME; OPEN STUDY; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RATING SCALE; RESTLESSNESS; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TARDIVE DYSKINESIA; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 10744222138     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.556     Document Type: Article

References (19)

1. Colom F, Vieta E, Martinez-Arán A, et al. 2002. Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale. Med Clin (Barc) 119: 366-371.
2. Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gastó C. 2000. Clinical factors associated to treatment non-compliance in euthymic bipolar disorder. J Clin Psychiatry 61: 549-554.
3. Csernansky JG, Mahmoud R, Brenner R. 2002. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med 346: 16-22.
4. Eerdekens M, Karchner K, Grossman F, Kramer M. 2003. Risperidone monotherapy in acute bipolar mania. Poster presented at I WPA Congress on Diagnosis in Psychiatry, Vienna, June 19-22.
5. Ghaemi SN, Sachs GS. 1997. Long-term risperidone treatment in bipolar disorder: 6-month follow up. Int Clin Psychopharmacol 12: 333-338.
6. Guille C, Sachs GS, Ghaemi SN. 2000. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 61: 638-642.
7. Guy W. Clinical global impressions. 1976. In ECDEU Assessment Manual for Psychopharmacology, Revised. US Dept of Health, Education, and Welfare, National Institute of Mental Health. Rockville, MD: 217-222.
8. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
9. Hirschfeld R, Keck PE, Karcher K, Kramer M, Grossman F, Vieta E. 2003. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Poster presented at The Third International Expert Review of Bipolar Disorders. Munich, April 6-8.
10. Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276.
11. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. 1987. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side-effects in neuroleptic-treated patients. Acta Psychiatr Scand 334 (Suppl.): 1-100.
12. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. 2002. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 159: 1146-1154
13. Segal J, Berk M, Brook S. 1998. Risperidone compared with both lithium and haloperidol in mania: a double blind randomised controlled study. Clin Neuropharmacol 21: 176-180.
14. Totten M, Zarate CA Jr, Centorrino F, Hegarty JI, Froeschl M, Zarate SB. 1996. Risperidone in the treatment of mania. J Clin Psychiatry 57: 249-253.
15. Vieta E, Gastó C, Escobar R. 1995. Treatment of disphoric mania with risperidone. Hum Psychopharmacol Clin 10: 491-492.
16. Vieta E, Goikolea JM, Corbella B, et al. 2001. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J Clin Psychiatry 62: 818-825.
17. Vieta E, Herraiz M, Parramon G, Goikolea JM, Fernández A, Benabarre A. 2002. Risperidone in the treatment of mania: efficacy and safety results from a large, multicenter, open study in Spain. J Affect Disord 72: 15-19.
18. Vieta E, Khanna S, Lyons B, Grossman F, Kramer M. 2003. Risperidone monotherapy in acute bipolar mania. Poster presented at The Third International Expert Review of Bipolar Disorders. Munich, April 6-8.
19. Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. 2003. An international, double-blind, randomized, controlled trial of mood stabilizers plus risperidone or placebo in the treatment of acute mania. Br J Psychiatry 182: 141-147.